Offer - Urjas Oil for just ₹ 1 X
Arpimune ME 50 Mg Capsule is a prescription medicine that is available as a Capsule. It is typically used for the treatment of Psoriasis, Liver transplant. Other than this, Arpimune ME 50 Mg Capsule has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Arpimune ME 50 Mg Capsule depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Arpimune ME 50 Mg Capsule are Increased hair growth, Loss of appetite. Apart from the aforementioned side effects, Arpimune ME 50 Mg Capsule can also lead to other problems, which have been listed below. Usually, these side effects of Arpimune ME 50 Mg Capsule go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Arpimune ME 50 Mg Capsule's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Arpimune ME 50 Mg Capsule's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Liver Disease must refrain from the use of Arpimune ME 50 Mg Capsule since this can cause severe adverse effects. Other conditions have been mentioned below in the Arpimune ME 50 Mg Capsule contraindications section.
Drug interactions for Arpimune ME 50 Mg Capsule have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Arpimune ME 50 Mg Capsule is considered safe while driving, and is addictive.
Arpimune ME 50 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Arpimune ME 50 Mg Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Arpimune ME. If you are pregnant, do not take Arpimune ME without a doctor's advice.
Is the use of Arpimune ME 50 Mg Capsule safe during breastfeeding?
Arpimune ME should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Arpimune ME 50 Mg Capsule on the Kidneys?
Arpimune ME has very mild side effects on the kidneys.
What is the effect of Arpimune ME 50 Mg Capsule on the Liver?
Side effects of Arpimune ME rarely affect the liver.
What is the effect of Arpimune ME 50 Mg Capsule on the Heart?
The heart can be affected by Arpimune ME. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Arpimune ME 50 Mg Capsule unless your doctor advises you to do so -
Is this Arpimune ME 50 Mg Capsule habit forming or addictive?
No, there is no any evidence that Arpimune ME 50 Mg Capsule is addictive.
Interaction between Food and Arpimune ME 50 Mg Capsule
There is no information on the effects of taking Arpimune ME 50 Mg Capsule with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Arpimune ME 50 Mg Capsule
No research has been done on this till date. Therefore, it is not known what the effect of taking Arpimune ME 50 Mg Capsule with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 879-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380